UNSPSC 85503806: Revision of autologous tissue substitute in upper artery, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in upper artery, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03WY47Z

UNSPSC 85503806, Revision of autologous tissue substitute in upper artery, percutaneous endoscopic approach, is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific surgical procedure involving tissue graft revision in upper arterial systems, yet the recent opportunities tagged under this code consist primarily of medical evaluation services, pharmacy benefit management, occupational health surveillance, and temporary clinical staffing — none of which involve surgical revision of autologous tissue grafts or arterial procedures. The mismatch between the code's clinical scope and the work actually being solicited suggests either a systematic tagging error in the underlying data or that this code sees little relevant procurement activity in state and local markets today.

Recent opportunities in this code span diverse issuing bodies including the City of Phoenix Retirement Office (independent medical evaluation services for disability pension determinations, RFP with October 16, 2026 deadline), the City of Long Beach (surgery benefit carve-out through Centers of Excellence networks, RFP due October 7, 2026), the Washington State Department of Transportation (occupational medical surveillance for ferry system employees across 14 Washington locations, RFP due October 9, 2026), Harris County Juvenile Probation Department (specialty and emergency medical services for detained youth, RFI due September 25, 2026), Collier County (pharmacy benefit management covering 2,400 enrolled employees with approximately $8.7 million historical annual spend, RFP due April 9, 2026), and Santa Clara County Health System (temporary ancillary clinical staffing pool including audiology, cardiology, radiology, orthopedic, and surgical services, RFP due October 7, 2026). The geographic spread includes Arizona, California, Washington, Texas, and Florida. No opportunities in this dataset reflect autologous tissue graft revision or upper arterial surgical procedures; advisors should verify whether this code correctly describes the procurement category or treat current activity as negligible for this specific commodity.